flecha

Producto

flecha
Technological Platform
Technological Platform Technological platform to reconsider molecules with angiogenic activities using robotic system.
High Throughput Screening (HTS) technologies have been widely accepted by pharmaceutical and biotechnology companies as an integral part of their drug discovery processes. Cell based high-content screening (HCS) – an extended version of HTS – is also being used more frequently to screen a larger number of compound libraries. Cell-based assays can be used to test compounds directly on living cells, which helps generate quality leads as well as hastens the process of lead validation.

Full integration of increasingly sophisticated cell analysis tools with enabling hardware will allow advancement of target validation and screening from ‘high-content’ to ‘high-context’ screening (HCxtS).
 
Link Más información
 
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Búsqueda
linea
Google Búsqueda personalizada
Área colaborativa de la BioRegión
Área colaborativa de la BioRegión
RSS
linea
RSS RSS Andalucía BioRegión
Acceso usuarios
linea
Email:
Contraseña:

Registrarse

¿Olvidó su contraseña?

Acceso empresas/centros
linea
Email:
Contraseña:

Registre su empresa

¿Olvidó su contraseña?

Nube de etiquetas
linea
Ver más etiquetas
Área colaborativa de la BioRegión